Financial Tear Sheet
Corporate Profile
Inovalon is a leading technology company that combines advanced
cloud-based data analytics, and data-driven intervention platforms to achieve
meaningful insight and impact in clinical and quality outcomes, utilization, and
financial performance across the healthcare landscape. Inovalon’s unique
achievement of value is delivered through the effective progression of Turning
Data into Insight, and Insight into Action®. Large proprietary datasets, advanced
integration technologies, sophisticated predictive analytics, data-driven
intervention platforms, and deep subject matter expertise deliver a seamless,
end-to-end capability that brings the benefits of big data and large-scale
analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps
in care, quality, data integrity, and financial performance – while bringing to
bear the unique capabilities to resolve them. Inovalon provides technology that
supports hundreds of healthcare organizations in 98.4% of U.S. counties and
Puerto Rico with cloud-based analytical and data-driven intervention platforms
that are informed by data pertaining to more than 804,000 physicians, 306,000
clinical facilities, and more than 137 million Americans. Through these
capabilities, and those of its subsidiary Avalere Health, which offers data-driven
advisory services and business intelligence to more than 200 pharmaceutical
and life sciences enterprises, Inovalon is able to drive high-value impact,
improving quality and economics for health plans, ACOs, hospitals, physicians,
consumers and pharma/life-sciences researchers.
Primary IR Contact
Investor Relations
E-mail:
inovalonshareholder@inovalon.com
Stock Performance
INOV (Common Stock)
Exchange
NASDAQ GS (US Dollar)
Price
$14.43
Change (%)
0.33 (2.24%)
Volume
779,754
52 Week Low
$13.85
Market Cap
$2,249,956,984
Rolling EPS
0.30
PE Ratio
49.5751
Shares Outstanding 152,436,110
Data as of 09/29/16 4:00 p.m. ET
Recent Headlines & Events
September 26, 2016 - 7:55 a.m.
Healthcare & Technology Innovators Convene in
Washington, D.C.
There are currently no events scheduled.
September 22, 2016 - 7:58 a.m.
Inovalon To Acquire Creehan & Company, IndustryLeading Specialty Pharmacy SaaS Platform
Page 1/2
September 12, 2016 - 7:56 a.m.
Inovalon and MDLIVE Bring Real-Time Advanced
Analytics to Telemedicine Marketplace
SEC Filings
Corporate Governance
Filing Date
Form
09/22/16
8-K
09/19/16
4
09/12/16
SC 13G/A
09/09/16
4
Keith R. Dunleavy, M.D.
Chief Executive Officer and
Chairman of the Board
Robert A. Wychulis
President
Christopher Greiner
Chief Product and Operations
Officer
Thomas Kloster, C.P.A.
(inactive)
Chief Financial Officer
Dan Mendelson
President of Avalere Health
Jason Z. Rose
Chief Strategic Development
Officer
Joe Rostock
Chief Technology Officer
Shauna Vernal
Senior Vice President and
Chief Legal Officer
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Page 2/2